- Enzymatic activity of moss-GAA - recombinantly expressed human alpha-glucosidase in moss P.patens
- Microplate-based assay enables comparison to marketed alpha-glucosidase
- CLARIOstar supports assay optimization and quick enzyme quantiﬁcation in samples from moss cultivation
Table of contents
The lysosomal enzyme acid alpha-glucosidase (GAA, Uniprot: P10253) is a hydrolase responsible for degradation of lysosomal glycogen to glucose. Genetically inherited deﬁciency of the GAA is known as Pompe disease. Patients suffering from this disorder accumulate glycogen in various body tissues – especially in skeletal and respiratory muscles. Currently, Myozyme® and Lumizyme® (Sanoﬁ Genzyme) - recombinant forms of human alfa glucosidase produced in Chinese Hamster Ovary (CHO) cells are the only approved treatments for Pompe disease.
Moss-GAA is an alternative recombinant version of human GAA produced in moss Physcomitrella patens. This proprietary expression system proﬁts from advantages, such as: eliminated risk of contamination by zoonotic pathogens and easy manipulation of the glycosylation pathway. Additionally, moss-made proteins exhibit highly homogenous glycosylation proﬁe, which can be beneﬁcial for targeted uptake of lysosomal enzymes, such as GAA.
The GAA producing moss strains are cultured in illuminated bioreactors and secrete moss-GAA into the cultivation supernatant. To measure the activity and quantify the recombinantly produced enzyme in culture samples, we established a known ﬂuorescence-based activity assay in a 96-well plate format, optimized its performance and conducted assay qualiﬁcation and initial validation.
Fluorescence-based enzyme activity assay using 4-methylumbelliferyl-α-D-glucopyranosid has been extensively used for the measurements of GAA concentration and activity in different types of samples. In this assay GAA hydrolyses the substrate to release the 4-methylumbelliferone that can be measured ﬂuorometrically. We used CHO-GAA-Myozyme® as a standard for assay development, optimization and its qualiﬁcation. Subsequently the developed assay was adapted (examination of possible matrix effects) for use with culture media samples originating from the moss cultivation.
Materials & Methods
- CLARIOstar® microplate reader (BMG LABTECH)
- 4-methylumbelliferyl α D-glucopyranoside (Roth)
- CHO-GAA–Myozyme® (Sanoﬁ Genzyme)
- Bovine Serum Albumin (Sigma)
- Black ﬂat-bottomed 96-well microplates (Roth) Shaker Titramax 1000 (Heidolph)
- Incubator (Binder)
20 µL of GAA containing sample was incubated with 80 µL assay buffer (56 mM citric acid, 88 mM Na2HPO4, 0,4% BSA, pH 4.4) containing 0.25 mM 4-MU α -D-glucopyranoside in a black 96-well microplate. The plate was agitated for 10 sec. at 900 rpm, covered with an adhesive microplate seal and incubated at 37°C protected from light for 60 min. The reaction was stopped by adding 200 µL of stop solution (0.1 M Glycine, 0.1 M NaOH) and ﬂuorescence was measured as outlined below.
|Optic settings||Fluorescence intensity, endpoint|
Dichroic: auto 402,5
|General settings||Number of flashes||40 per well|
|Settling time||0.2 s|
Results & Discussion
Calibration curve ﬁtting is a critical component of assay performance. We assessed linear regression and 4PL function for quality of the curve ﬁt by comparison of recovery rates for known amounts of CHO-GAA within the range 39,06 – 4000 ng/mL. Signiﬁcantly better ﬁt of the calibration curve, based on the visual assessment as well as better recovery rates between 100% – 120% throughout the whole working range have been achieved with 4-PL ﬁt, which was chosen as the assay’s calibration function.
2. Sensitivity (LOQ)
Limit of quantitation (LOQ) has been assessed based on the CV% of the CHO-GAA spike throughout the concentration range. The CV% increases above the 10% between the 31 and 39 ng/mL. This result corresponds well to the value based on customary signal-to-noise ratio 1:10 (interpolated from the mean absorbance of the blank + 10xSD of the blank), which was calculated to 36 ng/mL. The LOQ of the assay was set to 36 ng/mL.
Intra-assay precision was assessed by analysing three CHO-GAA samples in respective dilutions (2 dilutions per sample, each dilution in triplicate) covering the relevant working range. Intra-assay precision of %CV ≤ 5% was found. For the estimation of inter-assay precision corresponding samples were measured in following experiment, performed on a different day, by another operator. Inter-assay precision of %CV ≤ 8% was determined.
Table 1: Precision of GAA assay
|CHO-GAA [ng/mL]||Dil. factor||Mean||SD||CV%|
|CHO-GAA [ng/mL]||Dil. factor||Mean||SD||CV%|
4. Speciﬁc enzyme activity
The described assay was subsequently used to measure speciﬁc enzyme activity of different GAA preparations. For this an appropriate standard curve with 4-methylumbelliferone has been included in the microplate layout. The speciﬁc activity of recombinant GAA versions: CHO-GAA and moss-GAA has been measured, showing comparable values for both enzymes.
Table 2: Comparison of speciﬁc enzyme activity between the marketed version of GAA and the moss product (n=4)
|Speciﬁc activity (µmol/mg/min)|
This application note describes the adaptation, optimization and qualiﬁcation of a ﬂuorometric enzyme activity assay for acid alpha-glucosidase in 96 well plate. Microplate-based format enables fast and simultaneous quantiﬁcation of moss-GAA concentrations in multiple in-process samples. Analyzed assay parameters: linearity, sensitivity and precision demonstrate satisfactory ranges for the intended assay use.
The ﬁlter-based microplate reader CLARIOstar from BMG LABTECH provides an easy-to-use instrument, which measures this ﬂuorometric assay quickly and accurately. Furthermore, the complementary MARS Analysis Software Module is extremely helpful for evaluating and analyzing assay results.
*In 2020, the company Greenovation Biotech GmbH was transformed into a new company, Eleva GmbH.